Seiji Yoshitomi

Proteasome inhibitors can alter the signaling pathways and attenuate the P-glycoprotein-mediated multidrug resistance

Takeo Fujita, Kazuhiro Washio, Daisuke Takabatake et al. · International Journal of Cancer · 2005 · 60 citations · Full text

Tumor inhibitory effect of gefitinib (ZD1839, Iressa) and taxane combination therapy in EGFR‐overexpressing breast cancer cell lines (MCF7/ADR, MDA‐MB‐231)

Daisuke Takabatake, Takeo Fujita, Tadahiko Shien et al. · International Journal of Cancer · 2006 · 51 citations · Full text

Breast Oncology, Oncology, Medicine +15

Antitumor effect of gefitinib (‘Iressa’) on esophageal squamous cell carcinoma cell lines in vitro and in vivo

Fumikata Hara, Motoi Aoe, Hiroyoshi Doihara et al. · Cancer Letters · 2005 · 47 citations

Esophageal Cancer, Medicine, Cancer Cell Biology +9

PLC and PI3K Pathways are Important in the Inhibition of EGF-lnduced Cell Migration by Gefitinib (‘lressa’, ZD1839)

Tadahiko Shien, Hiroyoshi Doihara, Humikata Hara et al. · Breast Cancer · 2004 · 33 citations

Signal Transduction, Developmental Biology, Pi3k Pathways +8

Gefitinib, an epidermal growth factor receptor blockade agent, shows additional or synergistic effects on the radiosensitivity of esophageal cancer cells in vitro.

Naruto Taira, Hiroyoshi Doihara, Tetsuya Oota et al. · PubMed · 2006 · 26 citations

Human Esophageal Cancers, Esophageal Cancer, Radiation Therapy +14